Back to search
FDAFDA · Food and drugs·Recall number D-0278-2025

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Published March 26, 2025 · Recall initiated: March 7, 2025

Summary

FDA records drug Class II recall D-0278-2025, published March 26, 2025 and initiated March 7, 2025. Recalling firm: Slate Run Pharmaceuticals; Status: Completed; Reported quantity: 56,790 bottles; Lot: Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Slate Run Pharmaceuticals
Distributor
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Lot
Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04 recalled?

Yes. FDA published recall D-0278-2025 on March 26, 2025. Reported hazard: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter